Stocks · News reference
Scinai Immunotherapeutics Says It Received Nasdaq Notice Confirming Regained Compliance With Minimum Bid Price Rule
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Scinai Immunotherapeutics shares are trading lower after the company announced a $4 million private placement and warrant inducement transaction.
Scinai Immunotherapeutics Announces ~$4M Financing Via $1.20/ADS Private Placement And Warrant Inducement Repricing April 2026 Warrants To $1.20/ADS
Why Is Scinai Immunotherapeutics Stock Gaining Tuesday?
Scinai Immunotherapeutics stock jumped 27% after securing a $5.1M biopharma manufacturing deal. Details on SCNI's major contract win.